Hematology NewsMany die waiting for `last-chance’ therapyAugust 2, 2022Multiple MyelomaAggressive LymphomasALLCLLCellular TherapyMixed Topics
Oncology PracticeLife and death decisions: What keeps oncologists up at nightJuly 28, 2022Metastatic Breast CancerMixed TopicsBreast CancerCLL
Hematology NewsCAR T-cell therapy turns 10 and finally earns the word ‘cure’July 22, 2022ALLCLLCellular Therapy
Hematology NewsDrug shortages plague hematology, but preparedness helpsJuly 18, 2022CLLALLHodgkin LymphomaMixed TopicsBusiness of MedicineB Cell LymphomaMantle Cell Lymphoma
Hematology News‘Superior’ CLL regimen cuts chemo in halfJune 28, 2022CLLCellular TherapyMixed TopicsGene TherapyMyelodysplastic SyndromeAML
Hematology NewsFDA approves liso-cel as second-line therapy for LBCLJune 27, 2022B Cell LymphomaMixed TopicsCellular TherapyGene TherapyCLL
Hematology NewsStudies address ibrutinib bleeding risk in patients with CLL receiving Mohs surgeryMay 31, 2022Nonmelanoma Skin CancerMelanomaCLLLeukemia, Myelodysplasia, TransplantationMixed Topics
Hematology NewsThird-generation Black woman physician makes cancer research historyMay 24, 2022Mixed TopicsALLB Cell LymphomaHodgkin LymphomaMantle Cell LymphomaDiversity in MedicineAML
Hematology NewsEx–hospital porter a neglected giant of cancer researchMay 11, 2022ALLAggressive LymphomasB Cell LymphomaCLLDLBCLMantle Cell LymphomaMultiple Myeloma
